Sell. Market exuberance ignores cyclical capex drags and inevitable multiple normalization.
Bull: The AI-driven supercycle extends, justifying a premium multiple and mitigating cyclical capex drags. Revenue compounds at >15%.
Prolonged WFE Downturn: A severe and protracted cyclical downturn in wafer fabrication equipment spending driven by macro weakness structurally impairs revenue growth.
Sell. Composite fair value is $248.66. Downside risk (-43%) severely outweighs the speculative momentum holding the stock at current levels.
Position sizing playbook →| Market cap | $345.5B | |
|---|---|---|
| Revenue (ttm) | 28.2B | |
| Net income (ttm) | 7.8B | |
| EPS (ttm) | $9.76 | |
| Shares out | 793.6M | |
| P/E (trailing) | 44.6x | |
| P/E (forward) | 30.9x | |
| Dividend | $2.12 (0.49%) | |
| Volume | 8,164,912 | |
| Beta | 1.65 | |
| Price target | $358 | -17.8% |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | Trend |
|---|---|---|---|---|---|
| Period | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | Trend |
| Revenue | $25.79B | $26.52B | $27.18B | $28.37B | +3.2% |
| Gross profit | $11.99B | $12.38B | $12.90B | $13.81B | +4.8% |
| Operating income | $7.78B | $7.65B | $7.87B | $8.47B | +2.9% |
| Net income | $6.53B | $6.86B | $7.18B | $7.00B | +2.4% |
| EPS (diluted) | $7.44 | $8.11 | $8.61 | $8.66 | +5.2% |
| EBITDA | $8.27B | $8.47B | $8.79B | $9.98B | +6.4% |
| R&D | $2.77B | $3.10B | $3.23B | $3.57B | +8.8% |
| SG&A | $1.44B | $1.63B | $1.80B | $1.77B | +7.1% |
| Model | Fair value (mid) | Weight |
|---|---|---|
| Multi stage moat fade | $228 | 35% |
| Owner earnings | $271 | 20% |
| Forward earnings | $314 | 25% |
| Discounted earnings | $157 | 10% |
| Peg adjusted peer | $255 | 5% |
| FCFF DCF | $155 | 5% |
| Reverse DCF | $0.00 | 0% |
Recent company headlines from major financial publishers.
The AI-driven supercycle extends, justifying a premium multiple and mitigating cyclical capex drags. Revenue compounds at >15%.
Mean-reversion in multiples and market acknowledgment of the capex burden pull the valuation down to fundamental intrinsic value.
Protracted cyclical downturns and China export restrictions structurally impair growth, driving a severe derating.
| Model | Weight | FV / share | vs spot | Contribution |
|---|---|---|---|---|
| Multi stage moat fade | 35% | $228 | -47.6% | |
| Owner earnings | 20% | $271 | -37.8% | |
| Forward earnings | 25% | $314 | -27.9% | |
| Discounted earnings | 10% | $157 | -64.0% | |
| Peg adjusted peer | 5% | $255 | -41.4% | |
| FCFF DCF | 5% | $155 | -64.3% | |
| Reverse DCF | 0% | $0.00 | -100.0% | |
| Composite FV (weighted) | 100% | $249 | -42.9% |
| Ke ↓ / g → | 2.0% | 2.5% | 3.0% | 3.5% | 4.0% |
|---|---|---|---|---|---|
| 10.1% | $282 | $301 | $322 | $347 | $375 |
| 11.1% | $251 | $266 | $282 | $301 | $322 |
| 12.1% | $226 | $238 | $251 | $266 | $282 |
| 13.1% | $206 | $216 | $226 | $238 | $251 |
| 14.1% | $189 | $197 | $206 | $216 | $226 |
| Category | Weight | Score | Reading |
|---|---|---|---|
| Valuation | 11% | 5.0 | |
| Management | 11% | 6.9 | |
| Balance Sheet | 11% | 7.5 | |
| Profitability | 11% | 8.5 | |
| Revenue Growth | 11% | 2.5 | |
| Risk Assessment | 11% | 6.0 | |
| Competitive Moat | 11% | 9.0 | |
| Earnings Quality | 11% | 7.5 | |
| Capital Efficiency | 11% | 6.0 |
Upcoming earnings date and setup when available.